Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Change in Receivables (2022 - 2025)

HeartSciences' Change in Receivables history spans 3 years, with the latest figure at -$4350.0 for Q3 2025.

  • For Q3 2025, Change in Receivables changed N/A year-over-year to -$4350.0; the TTM value through Oct 2025 reached $10800.0, changed N/A, while the annual FY2025 figure was $4350.0, N/A changed from the prior year.
  • Change in Receivables reached -$4350.0 in Q3 2025 per HSCS's latest filing, down from $4350.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $10800.0 in Q1 2024 to a low of -$4350.0 in Q3 2025.
  • Average Change in Receivables over 3 years is $2119.8, with a median of $1014.5 recorded in 2022.